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Abstract
Controlled substance abuse is a global epidemic. Several factors that influence health
care providers prescribing habits have been presented in recent literature. However, the
existing evidence primarily reflects the prescribing habits of physicians, while relatively
little is known about the prescribing habits of nurse practitioners. The purpose of this
project is to evaluate the impact of a brief web-based continuing education module
targeting appropriate prescribing of controlled substances for recent graduate nurse
practitioners. The project served to assess the provider’s knowledge, attitude, and practice
compared to current integrated curriculum on prescribing and assess change in
knowledge. Two online educational modules and associated Pre and Post-Test knowledge
assessments, Demographics survey, and Course Evaluation survey were conducted on a
total of 22 new graduate nurse practitioners from Belmont University’s family nurse
practitioner program. Results were obtained, analyzed, and coded using Qualtrics Survey
Software, IMB SPSS Statistics Version 23 and by direct item analysis. The mean
knowledge score of participants significantly increased after completing the online
educational intervention. Most participants (63.6%) reported feeling adequately prepared
by their graduate level pharmacology course to prescribe controlled substances, however,
over three fourths of participants indicated they would “definitely” or “probably” make a
practice related change. Knowledge deficits pertaining to the ability to classify pain,
recognizing appropriate adjuvant therapies, utilizing systematic prescribing approaches,
and the ability to assess, screen, and monitor for substance use disorder (SUD) were
identified. Despite reports of feeling prepared to properly prescribe, knowledge deficits
were identified in graduates who have only been exposed to information surrounding
controlled substance prescribing found in current integrated curriculum. The online
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educational intervention was found to successful in increasing participant knowledge
after participation and was reported by respondents to be very practical and applicable to
clinical practice.

Keywords: opioid analgesics, primary healthcare, providers, attitudes, dosing, guidelines,
Tennessee, prescribing, pilot, nurse practitioner.
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Introduction and Background
Controlled substance abuse has become a worldwide problem, in particular opioid
abuse. In 2012 alone, health care providers wrote an estimated 250 million prescriptions
for opioid pain medications, enough for every person aged 18 or greater in the United
States to have a bottle of pills (Centers for Disease Control and Prevention, 2016). This is
an increase of approximately 170 million prescriptions since 1991 (National institute on
Drug Abuse, 2014). Since 1999, the number of unintentional overdose deaths from
prescription opioids has more than quadrupled (National Institute on Drug Abuse, 2014).
Due to this prescription increase, the potential for drug diversion is higher and there is
increased risk of inappropriate use, and ultimately user death (Volko, 2015).
In 1997 the Tennessee Nurses Association (TNA) passed legislation authorizing
nurse practitioners prescriptive authority of controlled drugs, Schedules II-V (Tennessee
Nurses Association, n.d.b). Since the passing of this bill, the Tennessee Controlled
Substance Monitoring Database (TNCSMD) identified that 35 of the top 50 prescribers of
controlled substances were Advanced Practice Registered Nurses (APRNs), including
nurse practitioners (Tennessee Nurses Association, n.d.a).
The American Association of Nurse Practitioners (2017) reports nurse
practitioners write approximately 23 prescriptions a day and 7,500 prescriptions within a
given calendar year. Between the years 2014 and 2015 an estimated 20,000 new nurse
practitioners successfully graduated from academic programs with the intention of
passing certification exams and entering the workforce (American Association of Nurse
Practitioners, 2017). With 83.4% of nurse practitioners being certified in an area of
primary care and over 50% of opioid prescriptions originating in the primary care setting,
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assessment of the prescribing practices of new nurse practitioners may contribute to a
clearer understanding of how this population of prescribers is contributing to the
epidemic (American Association of Nurse Practitioners, 2017; Hudspeth, 2016).
Additionally, a clearer understanding of the clinical context in which prescriptions are
written, as well as the education and training that prepares nurse practitioners as
prescribers may illuminate how APRN prescribers may be vulnerable to misprescribing.
Misprescribing may be purposeful or accidental and occur for a multitude of
reasons. Prescribers can be classified as dishonest are seeking personal financial gain.
Others may be classified dated in their knowledge, duped by drug-seeking patients,
dysfunctional due to overextension, or have disregard or disbelief for prescribing
guidelines, all leading to inappropriate prescribing of controlled substances (Spickard,
Dodd, Swiggart, Dixon, Pichert, 1998).
In early 2016, the CDC released standardized opioid prescribing guidelines to
support safe and responsible prescribing practices. Healthcare provider’s personal
attitudes and beliefs, legal and practice considerations, and concern over Federal Drug
Agency (FDA) and Drug Enforcement Agency (DEA) scrutiny have significantly
impacted their opioid prescribing habits (Chiauzzi, Trudeau, Zacharoff & Bond, 2011;
Fontana, 2008; Hooten & Bruce, 2011; Spitz, Moore, Papaleontiou, Granieri, Turner, &
Reid, 2011). However, the body of literature surrounding this topic focuses primarily on
the prescribing habits of medical doctors, while relatively little is known about whether
these variables have a similar impact on the prescribing practices of nurse practitioners.
With approximately 222,000 licensed nurse practitioners in active practice with
prescriptive authority for controlled substances in all 50 states, it is imperative to consider
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and assess factors that are unique to this population of prescribers (Department for
Professional Employees, 2016; American Association of Nurse Practitioners, 2017).
However, several continuing education methods were successful in furthering
prescriber knowledge and improving attitudes surrounding controlled substances
(McCracken, Biochat, &Eccleston, 2012; Roth& Burgess, 2008; Srivastava, Kahan, &
Jiwa, 2012)
The Center for Professional Health (2016) (CPH) at Vanderbilt University in
Nashville, Tennessee was established in 1998 to help physicians who needed behavioral
intervention and remediation related to their own substance abuse or the inappropriate
prescribing of controlled substances and to provide the Tennessee Board of Medical
Examiners with new options for physician remediation (Bill Swiggart, personal
communication, February 11, 2016). In the eighteen years since, CPH has served more
than 1,150 physicians from all over the United States and has developed a body of
research on the complexity of responsible prescribing, the psychological roots of
inappropriate prescribing and the unique challenges of clinicians who suffer from
substance abuse disorder (SUD). After years of research the Center for Professional
Health (2016) discovered the reasons for misprescribing were multi-factorial and were
able to group misprescribers into categories based on the reason for misprescribing. Thus,
remediation and intervention required deep introspection, reflection, SUD treatment
where necessary, and ongoing counseling and support.
Problem Statement
Despite increased regulation and guidance, nurse practitioners continue to be
among the top prescribers of controlled substances. To ensure our professional
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responsibility related to prescribing, it is imperative to assess the factors that influence
this unique population of controlled substance prescribers.
Purpose
The purpose of this scholarly project is to evaluate the efficacy of The Center for
Professional Health’s continuing education modules on appropriate prescribing of
controlled substances for recent graduate nurse practitioners and assess the provider’s
knowledge, attitude, and practice compared to current integrated curriculum on
prescribing. The objective of this study is to determine if pre and post-tests reveal an
increase in the provider’s knowledge, a change in attitude toward prescribing controlled
substances, and reveal any intended change in practice after reviewing the educational
modules. Additionally, this project is piloting the web based modules as an appropriate
and desirable format for targeting new providers within the first five years of practice to
increase knowledge surrounding controlled substance prescribing.
Review of Evidence
Guidelines
In early 2016 the CDC published The CDC Guideline for Prescribing Opioids for
Chronic Pain to provide health care providers with evidence-based recommendations for
the prescribing of pain medications for persons aged 18 years or greater in the primary
health care setting (CDC, 2016). The guidelines focus on the use of opioid analgesics in
the treatment of chronic, non-cancer, non-palliative care pain. The guidelines consists of
12 recommendations, each with an evidence-based rational. The CDC (2016) reports the
recommendations were formed by systematic review of scientific evidence, while still
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allowing consideration for the associated benefits and harms, values and preferences, and
resource allocation.
The Tennessee Department of Mental Health and Substance Abuse Services
(2014) has employed a statewide opioid prescribing guideline as well as strategies to
prevent and treat prescription drug abuse in the state. However, persistent prescribing,
diversion and accidental overdose in both the state and nation suggests awareness and
application of guidelines alone is not sufficient to change providers’ prescribing habits.
Factors Influencing Prescriber Habits
Several articles presented factors that influence prescribers, including knowledge,
personal attitude and beliefs, legal and practice considerations, and concerns of DEA and
FDA scrutiny (Chiauzzi, Trudeau, Zacharoff & Bond, 2011; Fontana, 2008; Hooten &
Bruce, 2011; Spitz, Moore, Papaleontiou, Granieri, Turner, & Reid, 2011).
Knowledge. Chiauzzi, Trudeau, Zacharoff and Bond (2011) consulted sixteen
nationally recognized experts in primary care, pain management, and addiction medicine
and identified knowledge, skills, and competencies most influential and critical for
primary care providers to effectively manage patients taking opioid analgesics. General
knowledge surrounding monitoring urine drug screens was the single most important skill
needed to properly treat and manage patients taking controlled substances. Knowledge
pertaining to assessment of risky behavior in patients ranked second and interpersonal
skills was third.
Fontana (2008) found that APRN’s prescriptive choices were influenced in part
by knowledge of the etiology of the pain. Participants reported this knowledge was
obtained from their formal education and hands on clinical experience. However,
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participants also reported feeling as though integrated curriculum on pain management
and pharmacology pertaining to controlled substances was not adequate in comparison to
the volume of patients seen for pain related complaints (Fontana, 2008). Hooten and
Bruce’s (2011) survey participants also reported the lack of formal education on the topic
manifested itself in feelings of fear related to causing addiction in patients.
Spitze, Moore, Papaleontiou, Granieri, Turner, and Reid (2011) found that
prescribers consider numerous patient factors when deciding to prescribe an opioid,
including the provider’s subjective experience of patient reliability, presence of a reliable
caregiver, etiology of the pain, and a documented history of benefiting from opioid
therapy. Providers were more likely to prescribe opioid therapy if the patient was reliable
or had a reliable caregiver to administer the medication, an identifiable etiology of pain,
and a history of successful opioid therapy. Likewise, Spitze, Moore, Papaleontiou,
Granieri, Turner, and Reid (2011) found providers were less likely to prescribe an opioid
if the patient had cognitive impairment, history of polypharmacy, or no reliable caregiver.
Personal attitudes & beliefs. The focus group of nurse practitioners in Fontana’s
(2008) study reported reluctance to prescribe certain medications if they or a family
member had a negative experience with the specific drug. In conjunction with Fontana
(2008), Spitze, Moore, Papaleontiou, Granieri, Turner, and Reid (2011) also found if a
practitioner had a prior clinical experience or personal experience with a painful
condition, he/she was more likely to prescribe opioid analgesics to the patient. In
addition, participants connected relying on their personal experience with a general lack
of formal education pertaining to controlled substance prescribing (Fontana, 2008). All
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participants reported believing better formal education in pain management would help
them better meet the needs of their patients (Fontana, 2008).
Spitze, Moore, Papaleontiou, Granieri, Turner, and Reid (2011) conducted a focus
group composed of 23 physicians and three nurse practitioners that revealed all providers
reported feeling cautious and uneasy when prescribing controlled substances.
Hooten and Bruce (2011) distributed a questionnaire to 128 medical doctors and
APRN’s and found that 27% of respondents believed that prescribing opioids could lead
to abusive behavior, patient addiction, and have an unfavorable impact on their clinical
practice. Overall Hooten and Bruce (2011) found that a large proportion of respondents
reported a negative attitude toward patients with abusive behavior and addiction, as well
as a negative attitude toward the effects of prescribing opioids on the complexity of
patient care. Prescribers reported that adding opioid therapy would increase the level of
management related to polypharmacy, the management of comorbid conditions, and
result in the need to obtain a more complex patient history.
Legal & practice considerations. Fontana (2008) revealed that many participants
felt constrained by their clinical practice setting and felt it necessary to protect one’s self
from the perceived personal risk involved with prescribing opioids. This protection
involved each practitioner assessing his/her own best interest, in relation to his/her role
within the clinical practice. Within certain practice settings practitioners must adhere to
protocols that do not allow for the personal consideration of practitioner (Fontana, 2008).
DEA & FDA scrutiny. Fontana (2008) critically examined subjective factors that
influence the prescribing habits of APRN’s, finding that clinicians often act in their own
best interest to reduce the risk of DEA scrutiny. Participants reported fear of DEA
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scrutiny even in situations where the pharmacologic choice was appropriate (Fontana,
2008). Hooten and Bruce (2011) and Spitze, Moore, Papaleontiou, Granieri, Turner, and
Reid (2011) also found that respondents are concerned about regulatory FDA scrutiny
when prescribing controlled substances.
Tennessee Requirements & Curriculum Audit
In order to obtain prescriptive authority in Tennessee, the state Board of Nursing
requires a minimum of three quarter hours of graduate level pharmacology instruction in
addition to a current unencumbered license as a registered nurse, a current national
certification in the appropriate nursing specialty area, and graduation from a master’s or
doctoral level nursing program (Tennessee Code Ann. §63-7-207). In order to prescribe
controlled substances, one must contact the Drug Enforcement Agency (DEA) and
complete the designated application before being issued a DEA number. The Tennessee
State Board of Nursing now requires two contact hours of continuing medical education
(CME) addressing controlled substance prescribing specifically as a requisite for the
renewal of the APRN license (Tennessee Code Ann. §1000-4-.05).
Nurse practitioners in Tennessee are required to renew certification every five
years; during the first years of practice, new graduate nurse practitioners rely on
information presented on controlled substances during the advanced pharmacology
portion of his/her graduate education course (Tennessee Code Ann. §1000-4-.05). In
Belmont University’s family nurse practitioner program there is one pre-class, voice-over
PowerPoint dedicated to the legal aspects of prescribing in Tennessee, one in-class
PowerPoint specific to analgesics, and a review of the CRAFFT Substance Abuse Screen
mnemonic tool. Within the analgesic PowerPoint, there are 16 slides specifically
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dedicated to controlled substances. Formal instruction and practice related to screening
for SUD in primary care is focused illicit drug and alcohol abuse and is not related to
controlled substance prescribing or pain management.
While this curriculum meets the standards set forth by the Tennessee Code Ann.
§63-7-207, whether this amount of information adequately prepares nurse practitioners to
properly prescribed controlled substances is unknown. Full application of the skills
surrounding controlled substance prescribing cannot be applied until the student has
successfully graduated, received a DEA number, and is in active clinical practice; this
process is on average one to two years after this information is initially presented in
Belmont University Graduate School of Nursing’s pharmacology course.
Educational Intervention
The need for continuing education and readily accessible guidelines is well
established in the literature. As a result, researchers have been working to implement new
interventions aimed to fill the identified gaps in knowledge and skills.
McCracken, Biochat, and Eccleston (2012) found that the demand for further
opioid education including both pain pathology and prescribing practices is high. The
authors also found that participants of the training intervention reported the Acceptance
and Commitment Therapy (ACT)-based educational intervention was more interesting
and engaging than the traditional standard education intervention. ACT training focuses
primarily on psychological flexibility, which entails the ability to act in accordance with
goals and values while minimizing influence from cognitive or emotional experiences
(McCracken, Biochat, and Eccleston, 2012). This suggests that health care professionals
prefer experiential exercises and the emotionally evocative methods of ACT to more
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passive didactic learning activities. The authors also report that participants showed an
increase in knowledge of controlled substance prescribing immediately post-intervention
and two weeks later, as evidenced by post-test results. Participants also reported having
an overall decrease of concern about addiction, professional scrutiny, and increased
controlled substance prescribing knowledge (McCracken, Biochat, & Eccleston, 2012).
Roth and Burgess (2008) also found that after attending an educational workshop
grounded in adult learning theory, participants reported significantly less fear of causing
addiction in patients, and less concern for professional and legal scrutiny related to
prescribing controlled substances.
Srivastava, Kahan, and Jiwa (2012) led a prospective cohort pilot study evaluating
the feasibility and effectiveness of a multifaceted educational intervention to improve the
opioid prescribing practices of physicians. Participants reported the didactic and case
discussion facet to be most helpful and enjoyable, while the e-mail and online chat room
were the least useful. Participants in this study reported increased application of treatment
guidelines, including routing screening for misuse and abuse after the educational
intervention.
Since CPH was formed over a decade ago, it has served over 1,150 providers, but
primarily physicians (Brown, Swiggart, Dewey, & Ghulyan, 2012; Charlene Dewey,
personal communication, February 11, 2016). Since 1997, when mid-level prescribers
gained prescriptive authority of scheduled drugs, The Center for Professional Health saw
an increase in the number of nurse practitioners and physician assistants attending the
remediation course (Bill Swiggart, personal communication, February 11, 2016). The
increase in nurse practitioner and physician assistant prescribers has lead The Center for
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Professional Health at Vanderbilt University to create the Proper Prescribing of
Controlled Prescription Drugs for Advanced Practice Nurses course aimed specifically at
this population (Charlene Dewey, personal communication, February 11, 2016).
Theoretical Model
Theoretical Model Overview & Concepts
In the 1950’s Donald Kirkpatrick developed the Kirkpatrick Evaluation Model to
objectively assess the efficacy and impact of a training intervention. The Kirkpatrick
Evaluation Model evaluates the value of any type of training transversely across four
levels: reaction, learning, behavior, and results (Kirkpatrick Partners, 2016) (See Figure
1).
The Vanderbilt University Center for Professional Health (CPH) utilizes this
model as the framework for assessing the effectiveness of the Proper Prescribing of
Controlled Prescription Drugs for Tennessee course in the classroom setting. Because
this Scholarly Project is a pilot study containing materials presented in the CPH course,
exact replication of the theoretical framework was necessary and no changes were made.
Level 1 assesses the reaction of the participants and the degree to which they
found the training to be favorable and relevant; Level 2 assesses the degree to which
participants acquired the intended knowledge, skills, and attitude (Kirkpatrick Partners,
2016). Level 3 assesses the degree to which participants apply the material obtained
during the training and Level 4 assesses the degree to which the desired outcomes occur
as a result of the training (Kirkpatrick Partners, 2016).
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Assumptions
Since the proposal and development of the Kirkpatrick Evaluation Model
researchers and trainers have identified three main assumptions that appear unintended by
Kirkpatrick himself.
The first assumption is that the levels are arranged in ascending value. Meaning,
the measure of Level 2- Learning, provides more information than the measure of Level
1- Reaction, and so forth (Alliger & Janak, 1998). The second assumption is that these
levels of evaluation are causally linked. This linkage denotes that a training intervention
leads to reaction, which leads to learning, which leads to behavior, which leads to results.
The third and final assumption is that the levels are positively inter-correlated. That is, a
set of positive interrelationships exist between the various evaluation levels (Alliger &
Janak, 1998). Each of these assumptions stems from the idea that the Kirkpatrick
Evaluation Model is a hierarchical model of training evaluation.
Theory Application
Kirkpatrick Evaluation Model is being utilized as the framework for this
Scholarly Project because of the step-by-step assessment of the effectiveness of a training
intervention. Levels 1, 2, and 3 of the Kirkpatrick Evaluation Model have been applied to
this Scholarly Project.
Level 1- Reaction, was applied by assessing the degree to which the participants
found this educational intervention to be useful. Four questions in the Course Evaluation
Survey assess the participant’s perspective of the overall quality of the information, the
perceived individual value, and the degree to which the individual’s needs were met.
Level 2- Learning, was applied by assessing the participant’s Pre and Post-Test Survey
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answers associated with each educational module. A correct change in answer from the
Pre-Test to Post-Test indicates that learning of the desired material has taken place.
Level 3-Behavior, was applied to the project by assessing the participant’s
intended behavior change. Two questions in the Course Evaluation Survey assess the
participant’s intended change in practice and personal change. Level 4- Results, was not
applied in this project, but will inform recommendations at the conclusion of the project.
Due to the short implementation period of the project, it was not feasible to assess the
long-term changes in prescriber behavior that occur after the educational intervention.
Project Design
This study was designed to pilot an online educational intervention for nurse
practitioner prescribers. The Project Leader used a cross-sectional, survey-based design
to evaluate the effectiveness of the intervention. Participant pre and post intervention
knowledge were measured immediately before and after the educational modules were
completed. A Demographics and Course Evaluation Survey were also completed to
determine participant satisfaction. The dependent variables of the study included
participant knowledge, attitude, and intent to change practice, all of which are ordinal
level measurements. All nominal level measurements obtained through multiple-choice
survey and demographic questions represented the independent variables. This project
was verified as exempt by Belmont University’s Institutional Review Board.
Project Population
All participants of this study were licensed nurse practitioners in the United States
who graduated from Belmont University’s Graduate School of Nursing between
December 2011 and May 2015. This sample represents new nurse practitioners who are

PROPER PRESCRIBING OF CONTROLLED DRUGS

18

in active clinical practice, but have not yet recertified and completed continuing
education hours related to controlled substance prescribing per the recertification
requirements found in the Tennessee Code Ann. §1000-4-.05. A purposive sample of
potential participants was identified through Belmont University’s Alumni directory,
accessed with permission from the Belmont University Alumni Association. Each
participant provided informed consent by voluntarily agreeing to participate in the study.
All participants were given full access to the two modules, there was no control group
assigned.
Inclusion criteria included: 1) successful completion and graduation from
Belmont University’s Graduate School of Nursing and 2) date of graduation between
December 2011 and May 2015. Exclusion criteria included: 1) graduates who
participated in the post-masters graduate program. These graduates were not eligible for
participation because it is unknown if he/she graduated from Belmont University’s
masters degree program prior to attending Belmont’s post-masters to Doctor of Nursing
Practice program.
Project Setting and Educational Intervention
Vanderbilt University’s Center for Professional Health creates online learning
modules to capture the content of the on-campus controlled substance prescribing
continuing medical education (CME), but in a format that is more cost effective and
accessible to a larger audience (Charlene Dewey, personal communication, February 11,
2016). It is important to note providers, including nurse practitioners, who register for the
on-campus program have already been identified by his/her governing body as having
irresponsible prescribing habits. Participation in the course is often mandatory and
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required to have their license re-instated. Offering this content online to new nurse
practitioners before recertification requirements represents an upstream intervention
aimed at early intervention for practitioners before they are identified as irresponsible
prescribers.
These modules were developed by Dr. Charlene Dewey, with advanced practice
registered nurses (APRN’s) in mind but have not yet been disseminated to a larger
audience. This Scholarly Project pilots two of the online modules developed by the CPH
to assess for knowledge gain within the designated sample group, indicating this content
can be used as prevention or early intervention for new nurse practitioners who may be at
high risk for irresponsible prescribing.
Learning objectives in Module 1: Overview of Pain and Tennessee Chronic Pain
Guidelines were related to appropriate classification of pain, adjuvant therapies,
pharmacologic treatments, and appropriate use of Tennessee chronic pain guidelines.
Learning objectives in Module 2: Best Clinical Practice were related to targeting and
screening for SUD and the use of clinical best practices appropriately.
Sources of Data/Data Collection Instruments
Two online educational modules and associated Pre and Post-Tests and Course
Evaluation form from PCH’s Proper Prescribing of Controlled Prescription Drugs for
Advanced Practice Nurses course were used in this study to determine if participants had
a change in knowledge, attitude, and/or practice. Module 1: Overview of Pain and TN
Chronic Pain Guidelines Pre and Post-Test survey was composed of eight multiplechoice questions and Module 2: Best Practice for Proper Prescribing of CPD Pre and
Post-Test survey was composed of five multiple-choice questions. The survey questions
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reflect a high level of rigor and require not only recall of information, but also
understanding, application, and analysis to draw connections among topics (Armstrong,
2017). The Course Evaluation survey was composed of seven multiple-choice questions.
A 12 question Demographics Survey was created to gather additional participant
information. (See Appendix A for Surveys).
The two educational modules were made available to participants through Electa
Live©. Qualtrics survey software was used to distribute the survey questions and to
collect Pre and Post-Test, Demographic Survey, and Course Evaluation data. Descriptive
data were analyzed using Microsoft Excel 2011.
Belmont University’s Graduate School of Nursing curriculum was audited for
content related to controlled substance prescribing, of which all participants received
during their education. Participants received comparable content related to controlled
substance prescribing; minimal adjustments were made annually to ensure content
accuracy (Leslie Higgins, personal communication, April 25, 2017). Course syllabi,
objectives, assignments, and evaluation items were assessed for content surrounding the
assessment and management of acute and chronic pain as well as the legal/regulatory
implications of controlled substance prescribing.
Data Collection Process/Procedures
Data collection took place from October 1 to December 1, 2016. Incentive to
participate included a $100 Visa gift card drawing. An initial invitational e-mail and
video was sent to potential participants. Those who accepted the invitation to participate
were then sent a subsequent e-mail containing directions, as well as a link and username
and password to access the PowerPoint based modules via the Electa Live© virtual
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classroom platform. In the directions, the participants were informed both how to access
Electa Live© and the PowerPoint modules. The directions also stated that the survey
links in the slides were to be completed in the order that they appeared and all responses
were anonymous and contained no identifying information (See Appendix B). All
Pre/Post-Test, Demographic Survey, and Course Evaluation data was saved using
Qualtrics for later evaluation and statistical analysis.
Results
Of the 114 graduates from Belmont University’s FNP program who were invited
to participate, 5.18% (N= 22) participated. Of which, 91% (N=20) completed all
components of the study including the online educational modules, pre and post-tests, and
demographics survey. Two participants failed to complete the course evaluation (N=20).
Demographics. The target population for this project was recent graduates early
in their careers as nurse practitioners. The socio-demographic characteristics of the
participants are presented in Table 1. Of the 22 participants, two identified as working in
urgent care, seven in primary care, one in pain management, six in a specialty practice
and six in “other” category practices. Over half (N=13) of the respondents reported
working in an urban setting, while the remaining (N=9) reported working in a rural
setting. Both years of active clinical practice and length of time at current practice ranged
from 0 to 5 years; the mean years of active practice was 2.14 years. The average time
participants had been working in their current clinical practice was 1.73 years. Of the
participants, eight reported working primarily with the adults, two with geriatrics, one
with pediatrics, five in mixed primary care, and six in “other” patient populations. The
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majority of participants, 90.0% (N=20), reported working in the state of Tennessee, while
4.5% (N= 1) reported Missouri, and 4.5% (N=1) Texas.
Practice Structure. The reported availability of the supervising physician varied,
four reported working in a private practice with a supervising physician available by
phone, three reported working with a group of NP’s with a supervising physician
available by phone, and fifteen reported working with a supervising physician available
on site. Over one third (N=17) of respondents reported having protocols in place
surrounding controlled substance prescribing, while the remaining (N=5) respondents
reported having no established protocols.
Controlled Substance Prescribing. Only one respondent reported not
prescribing controlled substances in clinical practice. Of those remaining, two thirds
(N=14) reported feeling prepared by the graduate pharmacology course they received at
Belmont University, while the remaining third (N=7) reported feeling unprepared.
Item 10 of the Demographic Survey allowed respondents to select all that apply
regarding major concerns related to controlled substance prescribing. The most
commonly chosen item was “pressure/demand from patients,” selected thirteen times,
followed by “continuing a standing prescription written by another provider”, selected ten
times. Participants chose “treating co-occurring pain and mental health” eight times,
“other” six times, and “pressure from supervising physician” one time. Of the
respondents, six reported either leaving or considering leaving a job due to controlled
substance prescribing habits at the practice.
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Module 1 Pre and Post Test Knowledge Assessment.
Each participant’s Module 1 Pre and Post Test scores were graded for accuracy.
The total scores were compared to assess whether there was an increase in answer
accuracy between the Pre and Post Test scores. A Paired t-test was computed on both the
Pre-Test and Post-Test total scores to assess for an increase in answer accuracy. The
analysis revealed that the educational intervention significantly increased participant
knowledge related to controlled substance prescribing. Of the eight items on the Module
1 Pre-Test, the average total score was five out of eight correct answers. Of the same
eight items on the Module 1 Post-Test, the average total score was seven out of eight
correct answers. The participants gained an average of 1.591 points on the Module 1
Post-Test, with the average score being 6.59 out of eight correct answers.
Due to sample size not meeting the 30 participant assumption of the Paired t-test,
the Wilcoxon matched-pairs test was used to validate statistical significance. In addition,
the Shapiro-Wilk test for normality was performed and the Wilcoxon matched-pairs test
was performed due to the measure not being normally distributed (See Table 3). The
Wilcoxon matched-pairs test concluded that a significant difference (p < .001) existed in
knowledge score before and after the educational intervention was completed (See Table
4).
An item analysis of Module 1 Pre and Post-Tests found there was a knowledge
deficit in topics pertaining to the following: classifying categories of pain based on
symptoms and duration of symptoms, as well as adjuvant pain treatment options. These
deficits were defined by summing the total number of correct answers for each item on
the survey. Respondents increased individual question scores by greater than or equal to
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ten points, which indicates an increase of 45% (N=22) over Pre-Test scores (See Table
5).
Module 2 Pre and Post Test Knowledge Assessment.
Of the five items on the Module 2 Pre-Test the average score was 2.45 out of five
correct answers. The participants gained an average of 2.19 points on the Module 2 PostTest, with the average score being 4.64 out of five correct answers. This gain is
statistically significant at p < .001 by the paired t-test (two-tailed) (See Table 2).
The item analysis of Module 2 Pre and Post-Tests revealed a knowledge deficit in
assessing for substance use disorder, employing a systematic approach to prescribing
controlled substances, and utilizing screening/monitoring tools for patients prescribed
controlled substances (See Table 6).
Course Evaluation. Each participant completed a course evaluation survey,
addressing the overall quality and value of the material. Of the respondents, 55% (N=11)
rated the quality of the material presented as “excellent”, and 45% (N=9) reported the
quality of the material to be “average”. Over half of the participants (N= 12) felt the
presented information was “extremely valuable” to them as an individual, and the
remaining eight felt it was “valuable”.
After completing the educational modules ten of participants reported that they
would “probably make a practice related change”, five reported they would “definitely
make a practice related change,” one reported they would “probably not make a practice
related change,” and two reported they would “definitely not make a practice related
change.”
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Discussion
Participant Knowledge Score. The main finding of this study was that
participant knowledge surrounding controlled substance prescribing significantly
increased after completing the educational modules. This finding is consistent with
McCracken, Biochat, and Eccleston (2012), who also found an increase in participant
knowledge and intent to change prescribing practices directly associated with educational
related to guidelines. This increase in knowledge score from Pre-Test to Post-Test is
consistent with Level 2-Learning, of the Kirkpatrick Evaluation Model. This indicates
that the educational intervention influenced increased learning of the desired material.
Although 63.6% of study participants reported feeling as though their graduate
level pharmacology course adequately prepared them to prescribe controlled substances
with confidence, over three fourths of the respondents indicated they would “definitely”
or “probably” make a practice related change after completing the educational
intervention. This suggests that despite the perception of adequate graduate level training
in pharmacology, the intention to change practice suggests that there was content
presented in the modules that the participants may not have known they were missing. In
comparison to Module 1, there was a larger increase in Module 2 Post-Test scores
suggesting information pertaining to systematic prescribing of controlled substances, as
well as targeting and screening of SUD is missing from graduate level courses, or
perhaps not presented in a manner that provokes knowledge retention.
The Tennessee Board of Nursing now requires continuing education credits
specifically related to controlled substance prescribing in order to renew certification
licensure every five years (Tennessee Code Ann. §1000-4-.05). This action by the Board
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of Nursing supports the importance and urgency of nurse practitioners needing this
information in primary care. The nurse practitioners in this sample represent providers
new to practice who have not yet completed the required continuing education related to
controlled substance prescribing, making them and their patients more vulnerable to
error.
Consistent with previous literature findings, this study also found knowledge
deficits to be a factor that could influence prescribing habits (Chiauzzi, Trudeau,
Zacharoff, & Bond, 2011; Fontana, 2008; Hooten & Bruce, 2011; Spitze, Moore,
Papaleontiou, Granieri, Turner, & Reid, 2011). Congruent with established literature, this
study found that practitioner knowledge deficits are present in the ability to classify pain,
recognize appropriate adjuvant therapies, utilize systematic prescribing approaches, and
the ability to assess, screen, and monitor for SUD (Chiauzzi, Trudeau, Zacharoff, &
Bond, 2011; Fontana, 2008).
This suggests, despite adequate completion of a graduate level family nurse
practitioner program, there is a significant time lapse between education and autonomous
practice. There is knowledge attrition that occurs during this time period, which may
impact prescribing practices. The findings of this study suggest refresher courses may
significantly increase the knowledge level of nurse practitioners who have not yet been
required by the Board of Nursing to complete continuing education directly related to
controlled substance prescribing.
Leading Concern Surrounding Prescribing. The deficit concerning practitioner
ability to assess, screen, and monitor for SUD in combination with the most frequently
reported concern surrounding controlled substance prescribing, the “pressure/demand
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from patients”, further suggests that new nurse practitioners lack the confidence to
identify and respond to SUD.
This study directly reports the pressures new nurse practitioners face from
patients who are seeking controlled substances and highlights the lack of knowledge in
assessing, screening, and monitoring for SUD in primary care. These findings illuminate
the unique role nurse practitioners play in the controlled substance abuse epidemic. New
nurse practitioners and their patients are vulnerable to these complex challenges and may
benefit from educational interventions targeting both the identified knowledge deficit and
the development of clinical skills to implement controlled substance guidelines, with
specific focus on screening for risk of SUD before starting controlled substances,
recognizing risk of SUD, and intervening appropriately when SUD is suspected or
confirmed.
Online Presentation Format. Although the mean knowledge score of the
participants increased significantly, the delivery method of the educational modules
proved to be unappealing to most who were invited to participate. Tjin, Tsoi, de Boer,
Croiset, Koster, and Kusurkur (2016) report participants find online formatting
convenient, however face-to-face meetings with peers was an important factor
influencing participation in healthcare continuing education courses. This is consistent
with McCracken, Biochat, and Eccleston’s (2012) findings, that health care professionals
prefer more engaging and emotionally evocative learning methods.
The low participation rate of this study highlights the challenge associated with
reaching this target population and the lack of awareness of their current knowledge
deficit. Often additional education is not sought out until the knowledge deficit has
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manifested itself as a liability to their professional livelihood or patient safety (Charlene
Dewey, personal communication February 11, 2016). The low response rate does not
indicate the quality of the content or even the delivery format is inadequate. In fact,
retention rates were high as were overall ratings of the material quality. This suggests
despite the online presentation format, participants were engaged in the content and
found the information valuable as a health care provider.
Piloting these modules in an online format was intended to gauge if the ease of
content accessibility increased the likelihood of participation. While continued research
needs to be conducted to further assess this presentation method, it can be inferred from
this study’s findings that the online format is successful in yielding an increase in
knowledge level but is not likely to create voluntary uptake of this information by new
graduate nurse practitioners until required by the Board of Nursing for recertification. It
can be expected that voluntary participation is more likely from those providers who have
already encountered challenges related to controlled substance prescribing in their
practice. The five-year time lapse between graduation and recertification of licensure
leaves the new graduate nurse practitioner at risk for misprescribing and ultimately poses
patient safety risks.
Implications for Practice. When the curriculum was audited, information
pertaining to controlled substance prescribing was found in one online voice-over
PowerPoint and only one test question throughout Belmont University’s family nurse
practitioner program pertained to controlled substance prescribing. Part of the solution to
the identified knowledge gap could be better integrating this content into graduate level
curriculum and enforcing it throughout multiple courses. This will better prepare students
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to recognize the wide range of comorbidities that often parallel SUD in controlled
substance seeking patients, such as co-occurring mental health issues.
Graduate level learning is highly motivated by what content is tested on exams
and national certification boards. In the future, if more emphasis is placed on the
importance of this topic, it is likely graduate level students will focus on and retain this
content into active clinical practice. CPH is working downstream to identify health care
providers who have already been recognized as having improper prescribing habits.
Integrating this content into graduate level education would work on the forefront as
early intervention and likely prevent mandated remediation by licensing bodies.
Strengths and Limitations. One strength of this study is that it demonstrates the
effectiveness of the educational intervention in improving participant knowledge. It also
evaluates new graduate nurse practitioners who have not yet been required to complete
controlled substance continuing education, required by the state of Tennessee.
Information pertaining to this specific group of nurse practitioners is unique because it
reflects these providers relying solely on the education they received in graduate school
to make clinical decisions. A gap in knowledge was identified between the Pre and PostTests, suggesting opportunity for further learning, specifically related to screening and
referral for the treatment of SUD. This information clarifies what improvements could be
made to better prepare nurse practitioners for clinical practice. Another strength of this
study is the full-bodied content within the educational modules created by CPH.
One limitation of this study is the small sample size composed of graduates of
only one educational institution. Due to this, it is questionable if the results of this study
are generalizable to the greater population of new graduate nurse practitioners. Future
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research efforts should involve sampling from graduates of other educational institutions
throughout Tennessee and ultimately the United States.
It is also noted that the immediate assessment of knowledge post-intervention, is
not necessarily indicative of knowledge retention long-term. Future research efforts
should include fully employing Level 4-Results of the Kirkpatrick Evaluation Model, and
evaluate the long-term results of the educational intervention. While this study shows an
immediate post-intervention increase in knowledge it is unknown at this time if the
participants will retain the information long-term. Future efforts would involve
evaluating the long-term retention of knowledge and the practical application of the selfreported intent to change clinical practice by participants. Another recommendation is to
display the correct answer and rationale to Pre and Post-Test questions after completion.
By providing constructive feedback participant long-term knowledge retention and
clinical practice may by influenced.
One final limitation would include the limited number of module assessment
questions that may not accurately capture comprehensive knowledge pertaining to
controlled substances. However, assessment items were written to assess high-level
learning requiring content recall, application, and analysis. A more lengthy assessment of
learning may contribute to response fatigue and increase attrition.
Conclusion
Six new providers reported considering leaving or leaving a job due to controlled
substance practices, thirteen reported experiencing pressure from patients to prescribe,
and only seventeen reported having protocols in place surrounding the prescribing of
controlled substances. Over 60% of participants reported feeling prepared to prescribe
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controlled substances with confidence, however, after completing the online educational
intervention over three fourths of the sample reported the intent to make a practice related
change. These data suggest new graduate nurse practitioners may be vulnerable to the
professional risks of misprescribing, leaving their patients vulnerable to iatrogenic
addiction, overdose, and accidental death.
These results offer strong support that additional resources in the form of
continuing education are needed before the mandated five-year recertification
requirement. This study found a significant increase in knowledge surrounding controlled
substance prescribing after completing the online educational intervention. However, the
difficulty arises in creating motivation in new providers to seek additional resources
before it is mandated by the state board for recertification or by law for remediation due
to improper prescribing practices.
With over 50% of opioid prescriptions originating in primary care and 83.4% of
nurse practitioners being certified in areas of primary care it is essential to better educate
and prepare new graduates on how to properly prescribe controlled substances (Hudspeth,
2016; American Association of Nurse Practitioners, 2016). The CDC has taken action by
releasing The CDC Guideline for Prescribing Opioids for Chronic Pain but this alone
does not address many of the reported issues surrounding controlled substance
prescribing, further supporting the need of additional resources for new graduate nurse
practitioners.
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Table 1. Demographics
Variable

N (%)

Clinical Practice Setting

22

Mean

Urgent Care 2 (9.1%)
Primary Care 7 (31.8%)
Pain Management 1 (4.5%)
Specialty Practice 6 (26.1%)
Other 6 (26.1%)
Clinical Practice Location

22

Rural 9 (40.9%)
Urban 13 (59.1%)
Years of Active Clinical
22
Practice
0-12 Months 7 (31.8%)
13 months-2 years 10 (45.5%)
25 months – 3 years 1 (4.5%)
37 months – 4 years 3 (13.6%)
49 months – 5 years 1 (4.5%)
5+ years 0 (0%)
Primary Patient
Population

22
Adult 8 (36.4%)
Geriatric 2 (9.1%)
Pediatric 1 (4.5%)

2.14

38

39
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Mixed Primary Care 5 (22.7%)
Other 6 (27.3%)
Length of Time at
22
Current Practice
0-12 Months 11 (50%)

1.73

13-24 Months 8 (36.4%)
25-36 Months 1 (4.5%)
37-48 Months 2 (9.1%)

Table 2. Paired t-Test
Paired Samples Statistics Module 1
Pair 1
Total Module
1 Pre-Test
Total Module
1 Post-Test

Mean

N

Std. Deviation

5.00

22

1.195

Std. Error
Mean
.255

6.59

22

.590

.126

Paired Samples Test Module 1

Pair 1Total
Module
1 PreTotal
Module
1-Post

Mean

Std.
Deviation

1.591

1.141

Std.
Error
Mean
.243

95%
Confidence
Interval
Lower
1.085
Upper
2.097

t

df

Sig (2
tailed)

6.542

21

.000
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Paired Samples Statistics Module 2
Pair 2
Mean
Total Module
2 Pre-Test
Total Module
2 Post-Test

N

Std. Deviation

2.45

22

.739

Std. Error
Mean
.157

4.64

22

.581

.124

Paired Samples Test Module 2
Mean
Std.
Std.
Deviation Error
Mean
Pair 22.182
.795
.169
Total
Module
2 PreTotal
Module
1-Post

95%
t
Confidence
Interval
Lower
12.872
1.829
Upper
2.534

Table 3. Shapiro-Wilk Test of Normality
Statistic
.645
Total Mod2Post
.846
Total Mod2Pre
.920
Total Mod1Pre
.677
Total Mod1Post

df
22
22
22
22

df

Sig (2
tailed)

21

.000

Sig .
.000
.003
.078
.000

Table 4. Wilcoxon Matched-Pairs Test
Test Statistics (a)
Total Module 1 PostTotal Module 1 Pre
-3.742 (b)
Z
< .001*
Asymp. Sig (2-tailed)
(a) Wilcoxon Signed Ranks Test
(b) Based on negative ranks
* Significant at .05

Total Module 2 PostTotal Module 2 Pre
-4.181 (b)
< .001*
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Table 5. Module 1 Item Analysis
Item
1
2
3
4
5
6
7
8

% Correct Pre
82 (N=18)
41 (N=9)
5 (N=1)
59 (N=13)
73 (N=16)
82 (N=18)
91 (N=20)
68 (N=15)

% Correct Post
100 (N=22)
86 (N=22)
0 (N=0)
91 (N=20)
18 (N=4)
100 (N=22)
100 (N=22)
100 (N=22)

% Gain
18
45
-5
32
-45
18
9
27

% Correct Post
100 (N=22)
86 (N=19)
95 (N=21)
86 (N=19)
95 (N=21)

% Gain
0
40
50
72
55

Table 6. Module 2 Item Analysis
Item
1
2
3
4
5

% Correct Pre
100 (N=22)
45 (N=10)
45 (N=10)
14 (N=3)
41 (N=9)
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Appendix A
Course Surveys
Module 1 Pre/Post Test
1. Pain can be classified into three main classifications. Which option lists the correct classifications of pain?
a)
b)
c)
d)
e)
f)

Central, peripheral, and complex regional
Neurologic, musculoskeletal, and central
Bone pain, soft tissue pain, and organ-based pain
Neuropathic pain, nociceptive pain and psychogenic pain
None of the above
I don’t know

2. Trigeminal neuralgia would best be classified into what category of pain?
a)
b)
c)
d)
e)
f)

Psychogenic
Soft tissue
Central and peripheral
Inflammatory
All of the above
I don’t know

3. Dr. Moab is a 35 yo male physician in family medicine. He is a healthy young man who abstains from alcohol for religious reasons
and has never used illicit street drugs. Dr. Moab presents to your urgent walk-in clinic after falling while hiking in Utah on a
family vacation 3 days ago. His fall resulted in a pretty badly bruised right hip/trochanteric area, a right twisted ankle and a
right lateral knee injury with bruising and superficial lacerations. He also has several lacerations on his right hand. His pain is
7/10. How would you best classify Dr. Moab’s pain based on time?
a)
b)
c)
d)
e)

Acute
Semi-acute
Intermittent
Chronic
I don’t know

4. How would you best classify Dr. Moab’s source of pain?
a)
b)
c)
d)
e)

Neuropathic
Somatic
Visceral
Complex regional pain syndrome
I don’t know

5. Mr. L presents with acute low back pain after moving a dresser. His pain is 5/10 that he describes as dull and achy with muscle
spasms. He has tenderness along the paraspinal muscles. Which adjuvant would be a good addition to pain control and PT?
a)
b)
c)
d)
e)
f)

SNRI
Pain rehabilitation
TENS unit
Bisphosphonates
Sympathetic nerve block
I don’t know

6. Mr. C presents with 7 days of 9/10 neck pain and stiffness after swimming at the start of summer. He doesn’t like taking
medications so has not tried anything and has mildly elevated LFTs. What would be an appropriate first line treatment for this type of
pain?
a)
b)
c)

Acetaminophen
Cyclobenzaprine
Hydrocodone
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d)
e)
f)
g)

Naproxen sodium
Codeine
None of the above
I don’t know

7. Ms. T is an office receptionist who complains of a pain that “radiates down” her right leg into her foot/great toe for 4 days. The pain
started as a mild ache in her back and then developed into a burning sensation. Sometimes it feels like an electric shock if she coughs or
sneezes. She also notes that prolonged sitting makes it worse. She denies fever, rash, bowel/bladder changes or leg weakness and no
acute traumas. What is your most likely diagnosis?
a)
b)
c)
d)
e)

Zoster
Avascular necrosis of the femoral head
Diabetes – peripheral neuropathy
Sciatica
I don’t know

8. Ms. J has chronic low back pain. She did not tolerate OTC NSAIDs and has hepatitis C. You referred physical therapy and she is
compliant but not significantly improved. What would be an appropriate next step if you follow the TN chronic non-malignant pain
guidelines algorithm?
a)
b)
c)
d)
e)
f)

Discharge from the office practice
Start an opioid at low dose
Screen for SU with UDT and check the drug monitoring program
Tell the patient the pain is complicated and requires treatment from an interventionist
None of the above
I don’t know

Module 2 Pre/Post-Test
1) A 32 yo female patient presents with hematuria x 3 weeks, mild right flank pain x 3 days, and nausea without vomiting x 1 day.
She states the pain is 3-5/10 at best and 7/10 at the worst. Currently, she is comfortable, pain level is 3/10 and she has not taken any
pain meds up to this time. The CT demonstrates 2 renal stones in the right ureter without obstruction and hydronephrosis, as well as 2
stones in the renal pelvis. If we prescribe CPD for this patient, what proper prescribing practices should be followed?
a)
b)
c)
d)
e)
f)
g)

Screen this patient for substance use.
Check the prescription drug monitoring program for your state.
Discuss contraception prior to prescribing CPD.
Discuss risk of dependence using a CPD.
All of the above
None of the above
I don’t know

2) Which patients, if any, would you screen using SBIRT?
a)
b)
c)
d)
e)
a)
b)

Pt is a 16 yo male with non-tender white patches in his mouth. They have been there for about 3 months.
Pt is a 23 yo female nursing student who blacked out after a night of partying and comes in for a superficial
her right forearm.
Pt is 44 yo homeless male requesting hydrocodone for his migraine HA.
Pt is 32 yo female with pain post-op day #1. Her friend suggested hydrocodone.
All of the above
None of the above
I don’t know

laceration on

3) A patient calls in early for refills twice in the past 4 months and the UDS is positive for marijuana. Which tool can you use to
assess for a substance use disorder?
a)
b)
c)
d)

The MMSE
CAGE-AID
BMP
Confirmatory UDT
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e)
f)
g)

All of the above
None of the above
I don’t know

4) What are the four steps in the four step approach to systematically prescribing CPDs in your practice?
a)
b)
c)
d)
e)
f)

SBIRT, check the PDMP, consent and document
Check family history, PDMP, UDS and document
Subjective/Objective, SBIRT, Assessment/Plan and document
HPI, pain levels, UDS and document
Screen for PDMP, UDS, CPD use and ORT
I don’t know

5) Which of the following screening/monitoring tools can be used for patient on CPDs?
a)
b)
c)
d)
e)

UDS, PDMP, Cage-AID, ORT, COMM
COMM, Audit, T-ACE, 5-A’s
ORT, UDS, CRAFFT and SOAPP-R
PDMP, MAST, Assist, Audit, T-ACE
I don’t know

Course Evaluation
1.

How would you rate the overall quality of the activity?
a. Poor
b. Average
c.
Excellent
d. Comments:

2.

How valuable was the activity to you as an individual?
a. No value at all
b. Valuable
c.
Extremely Valuable
d. Comments:

3.

How well did this activity meet your needs?
a. Did not meet my needs
b. Somewhat met my needs
c.
Completely met my needs
d. N/A
What did you value or like most about this activity?
a. Comments:

4.

5.

What about this activity can be improved?
a. Comments:

6.

Based on your participation in this activity, how likely are you to make a practice related change?
a. Will definitely make a change
b. Will probably make a change
c.
Will probably NOT make a change
d. Will definitely NOT make a change
e.
Not applicable
f.
Please describe the changes you will/probably will make or reasons for NOT making changes:
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7.

45

Based on your participation in this activity, how likely are you to make a personal related change?
a. Will definitely make a change
b. Will probably make a change
c.
Will probably NOT make a change
d. Will definitely NOT make a change
e.
Not applicable
f.
Please describe changes you will/probably will make or reasons for NOT making changes:

Demographics Survey
1.

What is your clinical practice setting
a.
Urgent Care
b. Primary Care
c.
Pain Management
d. Specialty Practice
e.
Other ______________________________

2.

What is your clinical practice location
a.
Rural area
b. Urban area
c.
Other _______________________________

3.

Years of active clinical practice
a.
___________________________

4.

Primary patient population
a.
Adult
b. Geriatric
c.
Pediatric
d. Family Practice
e.
Other ________________________________

5.

State of Practice
a.
_____________

6.

Year and month of graduation
a.
__________________________

7.

Length of time at current practice site
a.
_________________________________

8.

Select which best describes your practice organization
a.
Work in private practice with supervising physician available by phone
b. Work with a group of nurse practitioners with supervising physician available by phone
c.
Work with supervising physician available on site
d. Other ____________________________________________

9.

Does your practice have protocols in place guiding practice around prescribing controlled substances?
a.
Yes
b. No
10. Have you left a job or considered leaving your job because of controlled substance prescribing practices or expectations at
the site?
a.
Yes
b. No
c.
If yes, (enter skip logic)
11. Which of the following best describes your greatest challenge related to prescribing controlled substances? (check all that
apply)
a.
Pressure from supervising physician
b. Pressure/demand from patients
c.
Continuing a standing prescription written by another provider
d. Treating co-occurring pain & mental health
e.
Other______________
12. Do you feel that your graduate level pharmacology class prepared you to prescribe controlled substances with confidence?
a.
Yes

PROPER PRESCRIBINGN OF CONTROLLED DRUGS
b.
c.

No
Other______________
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Appendix B
Electa Live Access Instructions
Electa Live Access Instructions
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.

Open e-mail from noreply@school-network.net
Clink on URL link
Copy & paste username & password into appropriate boxes
Click “Login”
Select “Resource Library”
Select “Module 1- Overview of Pain” PowerPoint
Download to computer
Open PowerPoint
Read slides
Click the survey links on the slide
Complete the surveys in the order listed
Repeat steps 7-11 for “Module 2- Best Practice” PowerPoint
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